UB
ROIV icon

UMB Bank’s Roivant Sciences ROIV Stock Holding History

UMB Bank’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Sell
6,720
-76
-1% -$2.25K ﹤0.01% 682
2026
Q1 		$188K Buy
6,796
+176
+3% +$4.52K ﹤0.01% 714
2025
Q4 		$144K Buy
6,620
+620
+10% +$12.2K ﹤0.01% 789
2025
Q3 		$90.8K Buy
6,000
+117
+2% +$1.45K ﹤0.01% 910
2025
Q2 		$66.3K Buy
5,883
+1,740
+42% +$18.9K ﹤0.01% 1010
2025
Q1 		$41.8K Buy
4,143
+2,195
+113% +$23.7K ﹤0.01% 1126
2024
Q4 		$23K Buy
1,948
+831
+74% +$9.82K ﹤0.01% 1194
2024
Q3 		$12.9K Buy
1,117
+891
+394% +$10.1K ﹤0.01% 1392
2024
Q2 		$2.39K Buy
+226
New +$2.48K ﹤0.01% 1708

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

UMB Bank's ROIV Position: Q2 2026 in Review

UMB Bank reduced its Roivant Sciences (ROIV) stake by 1.1% in Q2 2026, selling an estimated $2.25K and leaving 6,720 shares worth $238K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

UMB Bank first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • UMB Bank held 6,720 shares of Roivant Sciences worth $238K as of Q2 2026.
  • UMB Bank sold 76 Roivant Sciences shares in Q2 2026, an estimated $2.25K.
  • Roivant Sciences made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #682 holding.
  • UMB Bank first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.